These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22615256)

  • 21. Succinic, fumaric, adipic and oxalic acid cocrystals of promethazine hydrochloride.
    Borodi G; Turza A; Onija O; Bende A
    Acta Crystallogr C Struct Chem; 2019 Feb; 75(Pt 2):107-119. PubMed ID: 30720448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
    Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
    J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals.
    Arenas-García JI; Herrera-Ruiz D; Morales-Rojas H; Höpfl H
    Eur J Pharm Sci; 2017 Jan; 96():299-308. PubMed ID: 27650458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
    Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
    Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
    Jindal A; Singh R; Tomar S; Dureja J; Karan M; Chadha R
    Pharm Res; 2021 Dec; 38(12):2129-2145. PubMed ID: 34904202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal.
    Aher S; Dhumal R; Mahadik K; Ketolainen J; Paradkar A
    Pharm Dev Technol; 2013 Feb; 18(1):55-60. PubMed ID: 21981663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectra investigation on surface characteristics of graphene oxide nanosheets treated with tartaric, malic and oxalic acids.
    Teng X; Yan M; Bi H
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():1020-4. PubMed ID: 24161864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuning mechanical properties of pharmaceutical crystals with multicomponent crystals: voriconazole as a case study.
    Sanphui P; Mishra MK; Ramamurty U; Desiraju GR
    Mol Pharm; 2015 Mar; 12(3):889-97. PubMed ID: 25587626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals.
    Panzade P; Shendarkar G; Kulkarni D; Shelke S
    Adv Pharm Bull; 2021 Sep; 11(4):772-776. PubMed ID: 34888225
    [No Abstract]   [Full Text] [Related]  

  • 34. Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy.
    Cassidy AM; Gardner CE; Jones W
    Int J Pharm; 2009 Sep; 379(1):59-66. PubMed ID: 19539735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing of Stable Co-crystals of Zoledronic Acid Using Suitable Coformers.
    Varma A; Laxmi P; Pai A; Pai G; Sg V; Badamane Sathyanarayana M
    Chem Pharm Bull (Tokyo); 2019; 67(8):816-823. PubMed ID: 31366831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
    Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U
    Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide.
    Di Martino A; Pavelkova A; Maciulyte S; Budriene S; Sedlarik V
    Eur J Pharm Sci; 2016 Sep; 92():276-86. PubMed ID: 27154260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).
    Patil R; Portilla-Arias J; Ding H; Inoue S; Konda B; Hu J; Wawrowsky KA; Shin PK; Black KL; Holler E; Ljubimova JY
    Pharm Res; 2010 Nov; 27(11):2317-29. PubMed ID: 20387095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
    Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
    Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic Basis of Cocrystal Dissolution Advantage.
    Cao F; Amidon GL; Rodríguez-Hornedo N; Amidon GE
    J Pharm Sci; 2018 Jan; 107(1):380-389. PubMed ID: 28989017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.